Cosmos Health Statistics
Total Valuation
Cosmos Health has a market cap or net worth of $12.48 million. The enterprise value is $23.93 million.
Important Dates
The next estimated earnings date is Monday, November 18, 2024, after market close.
| Earnings Date | Nov 18, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Cosmos Health has 17.75 million shares outstanding. The number of shares has increased by 118.72% in one year.
| Shares Outstanding | 17.75M |
| Shares Change (YoY) | +118.72% |
| Shares Change (QoQ) | +5.83% |
| Owned by Insiders (%) | 20.40% |
| Owned by Institutions (%) | 3.35% |
| Float | 9.25M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.19 |
| Forward PS | 0.39 |
| PB Ratio | 0.39 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.42 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.35, with a Debt / Equity ratio of 0.37.
| Current Ratio | 1.35 |
| Quick Ratio | 0.85 |
| Debt / Equity | 0.37 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -20.96 |
Financial Efficiency
Return on equity (ROE) is -56.61% and return on invested capital (ROIC) is -26.87%.
| Return on Equity (ROE) | -56.61% |
| Return on Assets (ROA) | -20.23% |
| Return on Capital (ROIC) | -26.87% |
| Revenue Per Employee | $458,983 |
| Profits Per Employee | -$234,145 |
| Employee Count | 123 |
| Asset Turnover | 0.87 |
| Inventory Turnover | 5.12 |
Taxes
| Income Tax | -65,873 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -38.86% in the last 52 weeks. The beta is 3.14, so Cosmos Health's price volatility has been higher than the market average.
| Beta (5Y) | 3.14 |
| 52-Week Price Change | -38.86% |
| 50-Day Moving Average | 0.91 |
| 200-Day Moving Average | 0.87 |
| Relative Strength Index (RSI) | 36.77 |
| Average Volume (20 Days) | 153,808 |
Short Selling Information
The latest short interest is 568,517, so 3.20% of the outstanding shares have been sold short.
| Short Interest | 568,517 |
| Short Previous Month | 651,566 |
| Short % of Shares Out | 3.20% |
| Short % of Float | 6.14% |
| Short Ratio (days to cover) | 2.26 |
Income Statement
In the last 12 months, Cosmos Health had revenue of $56.45 million and -$28.80 million in losses. Loss per share was -$1.90.
| Revenue | 56.45M |
| Gross Profit | 4.55M |
| Operating Income | -20.94M |
| Pretax Income | -18.54M |
| Net Income | -28.80M |
| EBITDA | -19.90M |
| EBIT | -20.94M |
| Loss Per Share | -$1.90 |
Full Income StatementBalance Sheet
The company has $365,018 in cash and $11.81 million in debt, giving a net cash position of -$11.45 million or -$0.64 per share.
| Cash & Cash Equivalents | 365,018 |
| Total Debt | 11.81M |
| Net Cash | -11.45M |
| Net Cash Per Share | -$0.64 |
| Equity (Book Value) | 32.12M |
| Book Value Per Share | 1.81 |
| Working Capital | 8.59M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$8.19 million and capital expenditures -$1.85 million, giving a free cash flow of -$10.04 million.
| Operating Cash Flow | -8.19M |
| Capital Expenditures | -1.85M |
| Free Cash Flow | -10.04M |
| FCF Per Share | -$0.57 |
Full Cash Flow StatementMargins
Gross margin is 8.05%, with operating and profit margins of -37.09% and -38.19%.
| Gross Margin | 8.05% |
| Operating Margin | -37.09% |
| Pretax Margin | -38.30% |
| Profit Margin | -38.19% |
| EBITDA Margin | -35.24% |
| EBIT Margin | -37.09% |
| FCF Margin | -34.87% |